INS and metabolic dysfunction-associated steatotic liver disease: However, another recent review indicates that KDs significantly reduce hepatic fat content and improve metabolic parameters, including insulin sensitivity and liver enzyme levels [39] and another recent study suggests that both KD and exogenous ketone supplementation present promising strategies for managing metabolic dysfunction-associated steatotic liver disease (MASLD) [19].